These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15026804)

  • 21. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
    Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/Kdr) expression.
    Marioni G; Giacomelli L; D'Alessandro E; Staffieri C; Guzzardo V; Staffieri A; Blandamura S
    Anticancer Res; 2008; 28(1B):551-7. PubMed ID: 18383901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance?
    Schimming R; Reusch P; Kuschnierz J; Schmelzeisen R
    J Craniomaxillofac Surg; 2004 Jun; 32(3):176-81. PubMed ID: 15113577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance.
    Yu JX; Zhang XT; Liao YQ; Zhang QY; Chen H; Lin M; Kumar S
    World J Gastroenterol; 2003 Dec; 9(12):2866-9. PubMed ID: 14669355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of immunocytochemical analysis of vascular endothelial growth factor (VEGF), and its two receptors, VEGF-R1 (Flt-1) and VEGF-R2 (Flk-1/KDR), in oesophagogastric cancer.
    Gray RT; O'Donnell ME; Maxwell P; McGuigan JA; Spence GM
    Int J Biol Markers; 2013 Apr; 28(1):63-70. PubMed ID: 23250775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathologic significance of CD105 mRNA expression in human breast carcinoma].
    Pang D; Liu F; Xue YW; Zhang QF
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):38-40. PubMed ID: 15771797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of endoglin (CD105) in cervical cancer.
    Zijlmans HJ; Fleuren GJ; Hazelbag S; Sier CF; Dreef EJ; Kenter GG; Gorter A
    Br J Cancer; 2009 May; 100(10):1617-26. PubMed ID: 19352388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
    Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
    Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
    Zhou S; Wang GP; Liu C; Zhou M
    BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical investigation of angiogenic factors in parathyroid proliferative lesions.
    Lazaris AC; Tseleni-Balafouta S; Papathomas T; Brousalis T; Thomopoulou G; Agrogiannis G; Patsouris ES
    Eur J Endocrinol; 2006 Jun; 154(6):827-33. PubMed ID: 16728542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF.
    Li Y; Zhai Z; Liu D; Zhong X; Meng X; Yang Q; Liu J; Li H
    Tumour Biol; 2015 Feb; 36(2):737-45. PubMed ID: 25286761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor and soluble Tie-2 receptor in colorectal cancer: associations with disease recurrence.
    Chin KF; Greenman J; Reusch P; Gardiner E; Marme D; Monson JR
    Eur J Surg Oncol; 2003 Aug; 29(6):497-505. PubMed ID: 12875855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in breast cancer patients.
    Beketic-Oreskovic L; Ozretic P; Rabbani ZN; Jackson IL; Sarcevic B; Levanat S; Maric P; Babic I; Vujaskovic Z
    Pathol Oncol Res; 2011 Sep; 17(3):593-603. PubMed ID: 21249485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.
    Kumar S; Ghellal A; Li C; Byrne G; Haboubi N; Wang JM; Bundred N
    Cancer Res; 1999 Feb; 59(4):856-61. PubMed ID: 10029075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
    Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
    Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays.
    Charpin C; Dales JP; Garcia S; Carpentier S; Djemli A; Andrac L; Lavaut MN; Allasia C; Bonnier P
    Clin Cancer Res; 2004 Sep; 10(17):5815-9. PubMed ID: 15355911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD105 expression is an independent predictor of survival in patients with endometrial cancer.
    Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O
    Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Feb; 9(2):716-21. PubMed ID: 12576440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.